QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-landos-biopharma-shares-are-trading-higher-by-over-170-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

 why-salarius-pharmaceuticals-shares-are-trading-higher-by-around-31-here-are-20-stocks-moving-premarket

Shares of Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) rose sharply in today’s pre-market trading following fourth-quarter re...

 dada-nexus-salarius-pharmaceuticals-and-3-stocks-to-watch-heading-into-monday

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as foll...

 salarius-pharmaceuticals-q4-2023-gaap-eps-022-beats-101-estimate

Salarius Pharmaceuticals (NASDAQ:SLRX) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate...

 salarius-provides-update-on-strategic-review-process-and-plans-to-support-ongoing-seclidemstat-clinical-trials-by-further-reducing-expenses-implementing-a-series-of-cost-savings-measures-designed-to-extend-expected-cash-runway-into-the-first-half-of-2025

Company implementing a series of cost-savings measures designed to extend Salarius' expected cash runway into the first hal...

 why-datchat-shares-are-trading-lower-by-around-33-here-are-20-stocks-moving-premarket

Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offe...

 salarius-pharmaceuticals-issued-us-patent-no-11773080-titled-deuterium-enriched-isoindolinonyl-azepanediones-and-related-compounds-and-methods-of-treating-medical-disorders-using-same

Expands IP portfolio with composition-of-matter protection into 2039 for novel molecular glues Protein degrader portfolio now i...

 investigator-initiated-phase-12-clinical-trial-using-salarius-pharmaceuticals-seclidemstat-in-combination-with-azacitidine-to-treat-hematologic-cancers-resumes-patient-enrollment

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) announces that the hematologic cancer Phase 1/2 clinical trial being conducted at ...

 salarius-pharmaceuticals-13d-filing-shows-elvin-lee-reported-609-stake-in-co-as-of-23-october-2023

- SEC Filing

 stocks-that-hit-52-week-lows-on-friday

  During the Friday's sesion, 157 stocks hit new 52-week lows.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION